A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy
Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic pr...
Saved in:
Published in | The Journal of urology Vol. 178; no. 6; p. 2385 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.12.2007
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic prostatectomy cases.
From July 2002 until December 2006 a total of 1,747 patients underwent radical prostatectomy at our institution (robotic assisted laparoscopic radical prostatectomy in 1,238, radical retropubic prostatectomy in 509). From these we selected the last 200 consecutive radical retropubic prostatectomies and 200 robotic assisted laparoscopic radical prostatectomies performed before August 2006. Preoperative clinical characteristics including age, clinical stage, prostate specific antigen and Gleason score were evaluated. Postoperatively pathological specimens were assessed for specimen weight, Gleason score, tumor volume, pathological stage and margin status. The incidence and location of positive surgical margins were compared between robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy.
Patients undergoing robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy had more favorable tumor characteristics including lower prostate specific antigen, clinical stage and Gleason score. No statistically significant differences were found between groups for prostate volume or tumor volume. However, tumor volume as a percentage of prostate volume was higher among radical retropubic prostatectomy compared to robotic assisted laparoscopic radical prostatectomy cases (17.7% vs 13%, p = 0.001). The overall incidence of positive surgical margins was significantly lower among the robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy cases (15% vs 35%, p <0.001). The incidence of positive surgical margins according to pathological stage for robotic assisted laparoscopic radical prostatectomy vs radical retropubic prostatectomy cases was 16 of 171 (9.4%) vs 33 of 137 (24.1%) for pT2 (p <0.001) and 14 of 28 (50%) vs 36 of 60 (60%) for pT3. In both groups the apex was the most common site of positive surgical margins with 52% in the robotic assisted laparoscopic radical prostatectomy group vs 37% in the radical retropubic prostatectomy group (p >0.05).
In the hands of surgeons experienced in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy, there was a statistically significant lower positive margin rate for patients undergoing robotic assisted laparoscopic radical prostatectomy. The most common location of a positive surgical margin in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy cases was at the apex. Patients treated with radical retropubic prostatectomy had higher risk features which may have independently influenced these results. The method of pathological specimen analysis and reporting may account for the higher positive margin rates in both groups compared to some reports. |
---|---|
AbstractList | Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of positive surgical margins in 200 sequential robotic assisted laparoscopic radical prostatectomy and 200 sequential open radical retropubic prostatectomy cases.
From July 2002 until December 2006 a total of 1,747 patients underwent radical prostatectomy at our institution (robotic assisted laparoscopic radical prostatectomy in 1,238, radical retropubic prostatectomy in 509). From these we selected the last 200 consecutive radical retropubic prostatectomies and 200 robotic assisted laparoscopic radical prostatectomies performed before August 2006. Preoperative clinical characteristics including age, clinical stage, prostate specific antigen and Gleason score were evaluated. Postoperatively pathological specimens were assessed for specimen weight, Gleason score, tumor volume, pathological stage and margin status. The incidence and location of positive surgical margins were compared between robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy.
Patients undergoing robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy had more favorable tumor characteristics including lower prostate specific antigen, clinical stage and Gleason score. No statistically significant differences were found between groups for prostate volume or tumor volume. However, tumor volume as a percentage of prostate volume was higher among radical retropubic prostatectomy compared to robotic assisted laparoscopic radical prostatectomy cases (17.7% vs 13%, p = 0.001). The overall incidence of positive surgical margins was significantly lower among the robotic assisted laparoscopic radical prostatectomy compared to radical retropubic prostatectomy cases (15% vs 35%, p <0.001). The incidence of positive surgical margins according to pathological stage for robotic assisted laparoscopic radical prostatectomy vs radical retropubic prostatectomy cases was 16 of 171 (9.4%) vs 33 of 137 (24.1%) for pT2 (p <0.001) and 14 of 28 (50%) vs 36 of 60 (60%) for pT3. In both groups the apex was the most common site of positive surgical margins with 52% in the robotic assisted laparoscopic radical prostatectomy group vs 37% in the radical retropubic prostatectomy group (p >0.05).
In the hands of surgeons experienced in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy, there was a statistically significant lower positive margin rate for patients undergoing robotic assisted laparoscopic radical prostatectomy. The most common location of a positive surgical margin in robotic assisted laparoscopic radical prostatectomy and radical retropubic prostatectomy cases was at the apex. Patients treated with radical retropubic prostatectomy had higher risk features which may have independently influenced these results. The method of pathological specimen analysis and reporting may account for the higher positive margin rates in both groups compared to some reports. |
Author | Chan, Robert C Chang, Sam S Herrell, S Duke Cookson, Michael S Baumgartner, Roxy Clark, Peter E Smith, Jr, Joseph A |
Author_xml | – sequence: 1 givenname: Joseph A surname: Smith, Jr fullname: Smith, Jr, Joseph A organization: Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765, USA – sequence: 2 givenname: Robert C surname: Chan fullname: Chan, Robert C – sequence: 3 givenname: Sam S surname: Chang fullname: Chang, Sam S – sequence: 4 givenname: S Duke surname: Herrell fullname: Herrell, S Duke – sequence: 5 givenname: Peter E surname: Clark fullname: Clark, Peter E – sequence: 6 givenname: Roxy surname: Baumgartner fullname: Baumgartner, Roxy – sequence: 7 givenname: Michael S surname: Cookson fullname: Cookson, Michael S |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17936849$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kEtOwzAQhi0Eog-4AAvkCySM7SSOl1XFS6rEpvvKscfgqomj2EXqjTgmFoUlqxn9M98_jwW5HMKAhNwxKBmw5mFf7o9TKDmALKEtAdoLMmc1l4WQis_IIsY9AKtqya_JjEklmrZSc_K1oib0o558DAMNjqYPpH4w3uJgkOrB0kMwOvlzdQzRJ_-JNB6nd2_0gfY6J0PMDJ1CF5I3VMfoY8JM6mwcogljVidtf4AxK0knNCn0p58BYcQMY5rCeOz-67whV04fIt7-xiXZPj1u1y_F5u35db3aFKaGOhVSN07UwoBDY1FwBYqrTjHnoGlMpbVsrQXeCRDGVsqhEMiEq7BqpOgcX5L7s21epUe7GyefLzzt_j7GvwHdQnTv |
CitedBy_id | crossref_primary_10_1093_jjco_hyy092 crossref_primary_10_1111_j_1442_2042_2012_03193_x crossref_primary_10_1111_j_1464_410X_2010_09941_x crossref_primary_10_1007_s11701_010_0171_5 crossref_primary_10_1111_j_1464_410X_2009_08685_x crossref_primary_10_1016_j_ucl_2009_11_008 crossref_primary_10_1007_s00345_014_1393_3 crossref_primary_10_1177_1756287210364207 crossref_primary_10_1053_j_seminoncol_2013_04_004 crossref_primary_10_2214_AJR_14_13280 crossref_primary_10_1016_j_acuro_2012_11_015 crossref_primary_10_1111_and_13533 crossref_primary_10_1155_2011_645030 crossref_primary_10_1016_j_uromx_2016_01_002 crossref_primary_10_1089_end_2012_0013 crossref_primary_10_19161_etd_1168102 crossref_primary_10_1111_j_1464_410X_2008_08084_2_x crossref_primary_10_1007_s00345_013_1230_0 crossref_primary_10_1111_iju_12447 crossref_primary_10_1007_s11701_010_0200_4 crossref_primary_10_1002_jso_24109 crossref_primary_10_1089_end_2009_0121 crossref_primary_10_1007_s11701_009_0169_z crossref_primary_10_1007_s11701_008_0082_x crossref_primary_10_1007_s11934_011_0180_6 crossref_primary_10_3349_ymj_2009_50_2_177 crossref_primary_10_1089_end_2010_0349 crossref_primary_10_1016_j_eururo_2013_10_030 crossref_primary_10_1097_MOU_0b013e3282f517d6 crossref_primary_10_3390_cancers14030688 crossref_primary_10_1089_end_2010_0184 crossref_primary_10_1007_s11701_008_0122_6 crossref_primary_10_1111_j_1464_410X_2008_07607_x crossref_primary_10_1007_s10147_022_02278_7 crossref_primary_10_5410_wjcu_v5_i1_24 crossref_primary_10_1007_s11701_011_0247_x crossref_primary_10_1016_j_urolonc_2022_08_012 crossref_primary_10_1089_end_2011_0507 crossref_primary_10_1111_j_1464_410X_2009_09176_x crossref_primary_10_3390_cancers13010106 crossref_primary_10_1016_j_juro_2012_09_169 crossref_primary_10_3349_ymj_2016_57_5_1165 crossref_primary_10_1371_journal_pone_0249991 crossref_primary_10_1111_j_1442_2042_2010_02546_x crossref_primary_10_1016_j_eururo_2009_11_008 crossref_primary_10_18632_oncotarget_13332 crossref_primary_10_1016_j_urology_2009_09_085 crossref_primary_10_1038_aja_2008_10 crossref_primary_10_1016_j_urolonc_2011_03_003 crossref_primary_10_1016_j_urolonc_2016_03_021 crossref_primary_10_1007_s11934_008_0043_y crossref_primary_10_1016_j_eursup_2010_02_009 crossref_primary_10_1038_aja_2008_11 crossref_primary_10_1111_bju_12509 crossref_primary_10_1016_j_juro_2014_05_124 crossref_primary_10_1016_j_urolonc_2011_07_013 crossref_primary_10_1007_s00120_008_1656_y crossref_primary_10_1016_j_juro_2009_02_139 crossref_primary_10_1186_1748_717X_7_194 crossref_primary_10_1590_S1677_55382009000200002 crossref_primary_10_1016_j_eururo_2010_02_017 crossref_primary_10_1111_j_1464_410X_2011_10053_x crossref_primary_10_1089_end_2008_0056 crossref_primary_10_1038_s41598_021_93860_y crossref_primary_10_1089_end_2009_0144 crossref_primary_10_1016_j_eururo_2013_11_018 crossref_primary_10_1007_s00345_020_03298_6 crossref_primary_10_1155_2011_878323 crossref_primary_10_1016_j_eururo_2014_07_012 crossref_primary_10_1097_MOU_0b013e32834d5455 crossref_primary_10_1089_end_2017_0693 crossref_primary_10_1038_modpathol_2010_178 crossref_primary_10_1111_bju_12258 crossref_primary_10_1016_j_eururo_2011_11_053 crossref_primary_10_1007_s11701_011_0266_7 crossref_primary_10_1038_srep27419 crossref_primary_10_1007_s00345_009_0379_z crossref_primary_10_1007_s11701_008_0121_7 crossref_primary_10_1111_j_1464_410X_2009_09158_x crossref_primary_10_1007_s11701_011_0307_2 crossref_primary_10_1586_erp_10_46 crossref_primary_10_1016_j_juro_2011_04_079 crossref_primary_10_1016_j_juro_2016_01_105 crossref_primary_10_1089_end_2011_0336 crossref_primary_10_1016_j_urolonc_2009_07_021 crossref_primary_10_1016_j_acuroe_2012_11_019 crossref_primary_10_1111_j_1442_2042_2008_02232_x crossref_primary_10_1016_j_ejso_2011_09_006 crossref_primary_10_1016_j_urology_2008_11_011 crossref_primary_10_15406_unoaj_2018_06_00221 crossref_primary_10_1590_S1677_5538_IBJU_2015_0385 crossref_primary_10_1016_j_humpath_2011_04_029 crossref_primary_10_1111_j_1464_410X_2009_08996_x crossref_primary_10_1155_2013_768647 crossref_primary_10_1111_j_1464_410X_2007_07440_x crossref_primary_10_1007_s00120_008_1657_x crossref_primary_10_1016_j_juro_2009_11_039 crossref_primary_10_1016_j_aju_2011_12_001 crossref_primary_10_1016_j_eururo_2014_01_039 crossref_primary_10_1590_s1677_5538_ibju_2017_0702 crossref_primary_10_1111_bju_15133 crossref_primary_10_1111_j_1464_410X_2009_08419_x crossref_primary_10_1016_j_ajur_2019_12_004 crossref_primary_10_1111_j_1442_2042_2009_02437_x crossref_primary_10_1007_s11701_009_0162_6 crossref_primary_10_1089_end_2011_0569 crossref_primary_10_1089_end_2008_0398 crossref_primary_10_1007_s11701_012_0335_6 crossref_primary_10_1177_2051415813519628 crossref_primary_10_1007_s00261_011_9805_y crossref_primary_10_1148_radiol_14140044 crossref_primary_10_1159_000366008 crossref_primary_10_1177_107327481502200305 crossref_primary_10_1007_s13193_016_0582_5 crossref_primary_10_1016_j_eururo_2010_01_040 crossref_primary_10_3346_jkms_2015_30_11_1631 crossref_primary_10_1016_j_urolonc_2009_03_031 crossref_primary_10_1136_jclinpath_2011_200533 crossref_primary_10_2478_jbcr_2019_0023 crossref_primary_10_1038_modpathol_2010_155 crossref_primary_10_1016_j_urolonc_2010_10_004 crossref_primary_10_1186_1471_2490_14_6 crossref_primary_10_1111_j_1365_2559_2011_04002_x crossref_primary_10_1007_s10147_019_01587_8 crossref_primary_10_1053_j_ro_2015_08_004 crossref_primary_10_1007_s11701_009_0158_2 crossref_primary_10_1111_j_1464_410X_2010_09336_x crossref_primary_10_1016_j_eururo_2009_01_036 crossref_primary_10_1111_j_1464_410X_2009_08895_x crossref_primary_10_1111_j_1464_410X_2011_10529_x crossref_primary_10_1155_2011_673021 crossref_primary_10_1001_jamanetworkopen_2020_1894 crossref_primary_10_1016_j_acuroe_2015_01_001 crossref_primary_10_1089_lap_2011_0388 crossref_primary_10_1007_s00432_022_04243_3 crossref_primary_10_1016_j_juro_2011_03_112 crossref_primary_10_1007_s00345_013_1149_5 crossref_primary_10_1111_j_1464_410X_2012_11503_x crossref_primary_10_1016_S0976_0016_11_60185_3 crossref_primary_10_1016_j_juro_2009_11_017 crossref_primary_10_1089_end_2013_0393 crossref_primary_10_1007_s11255_012_0262_5 crossref_primary_10_1111_j_1464_410X_2010_10077_x crossref_primary_10_1016_j_acuro_2013_07_011 crossref_primary_10_1016_j_acuroe_2013_11_011 crossref_primary_10_1111_iju_13281 crossref_primary_10_1002_jso_24040 crossref_primary_10_1111_iju_12070 crossref_primary_10_1007_s11701_011_0313_4 crossref_primary_10_1016_j_juro_2009_03_028 crossref_primary_10_1016_j_suronc_2009_02_009 crossref_primary_10_1016_j_acuro_2014_02_021 crossref_primary_10_1007_s00120_012_2881_y crossref_primary_10_5980_jpnjurol_101_1 crossref_primary_10_1016_j_eururo_2017_11_035 crossref_primary_10_1016_j_juro_2015_03_009 crossref_primary_10_1590_S1677_5538_IBJU_2013_05_05 crossref_primary_10_1053_j_semdp_2011_10_001 crossref_primary_10_1016_j_juro_2008_10_022 crossref_primary_10_12954_PI_12001 crossref_primary_10_1007_s00345_008_0293_9 crossref_primary_10_1586_era_10_35 crossref_primary_10_1016_j_urolonc_2009_08_015 crossref_primary_10_32948_auo_2020_10_08 crossref_primary_10_4111_kju_2013_54_12_824 crossref_primary_10_1016_j_eururo_2012_08_059 crossref_primary_10_2217_cer_13_23 crossref_primary_10_1016_j_eururo_2010_10_026 crossref_primary_10_1200_EDBK_175666 crossref_primary_10_1007_s11701_021_01333_1 crossref_primary_10_1111_j_1464_410X_2010_09662_x crossref_primary_10_1007_s11701_020_01179_z crossref_primary_10_1016_j_ajur_2022_02_014 crossref_primary_10_1016_j_juro_2009_08_037 crossref_primary_10_1016_j_urology_2008_08_484 crossref_primary_10_1007_s11934_013_0327_8 crossref_primary_10_1016_j_maturitas_2009_12_011 crossref_primary_10_1016_j_juro_2015_08_092 crossref_primary_10_1007_s13629_011_0058_x crossref_primary_10_1016_j_juro_2009_06_046 crossref_primary_10_1016_j_urolonc_2011_12_002 crossref_primary_10_1016_j_purol_2013_02_003 crossref_primary_10_1016_j_urology_2009_11_079 crossref_primary_10_1111_j_1464_410X_2010_09795_x crossref_primary_10_1111_j_1464_410X_2011_10501_x crossref_primary_10_1038_pcan_2009_17 crossref_primary_10_5301_RU_2013_10834 crossref_primary_10_1002_pros_23114 crossref_primary_10_1007_s13193_016_0594_1 crossref_primary_10_1586_era_11_85 crossref_primary_10_1089_end_2009_0212 crossref_primary_10_3390_medicines5020032 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1016/j.juro.2007.08.008 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3792 |
ExternalDocumentID | 17936849 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- --K .55 .GJ .XZ 08P 0R~ 123 1B1 1CY 354 3O- 4.4 457 4G. 4Q1 4Q2 4Q3 53G 5RE 5VS 7-5 AAAAV AAEDT AAEDW AAGIX AAHPQ AAIQE AAJCS AAKAS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO ABASU ABCQX ABDIG ABJNI ABLJU ABMAC ABOCM ABPPZ ABVCZ ACGFS ACILI ACLDA ACOAL ACXJB ADGGA ADHPY ADMUD ADNKB ADPAM ADZCM AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFTRI AFUWQ AGHFR AHOMT AHQNM AHRYX AHVBC AI. AINUH AITUG AIZYK AJIOK AJNWD AJZMW AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ ASGHL ASPBG AVWKF AZFZN BCGUY BELOY BYPQX C45 C5W CGR CS3 CUY CVF DIWNM DU5 EBS ECM EEVPB EIF EJD ERAAH EX3 F5P FCALG FDB FEDTE FGOYB GBLVA GNXGY GQDEL HLJTE HVGLF HZ~ H~9 IH2 IHE IKREB IKYAY IPNFZ J5H KMI L7B M41 MJL MO0 N4W NPM NQ- NTWIH O9- OAG OAH OB3 OBH ODMTH OGROG OHH OL1 OVD OWU OWV OWW OWY OWZ P2P QTD R2- RIG RLZ ROL RPZ SEL SES SJN SSZ TEORI TSPGW UDS UNMZH UV1 VH1 VVN WOW X7M XH2 XYM YFH YOC ZCG ZFV ZGI ZXP ZY1 ZZMQN |
ID | FETCH-LOGICAL-c505t-7a6f353c0fecde3290929b91ff066c4aa78dd02b303cd49fe33e13f4e4673bf2 |
IngestDate | Tue Oct 15 23:38:53 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c505t-7a6f353c0fecde3290929b91ff066c4aa78dd02b303cd49fe33e13f4e4673bf2 |
PMID | 17936849 |
ParticipantIDs | pubmed_primary_17936849 |
PublicationCentury | 2000 |
PublicationDate | 2007-12-01 |
PublicationDateYYYYMMDD | 2007-12-01 |
PublicationDate_xml | – month: 12 year: 2007 text: 2007-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of urology |
PublicationTitleAlternate | J Urol |
PublicationYear | 2007 |
References | 17936808 - J Urol. 2007 Dec;178(6):2249 18823916 - J Urol. 2008 Nov;180(5):2257; author reply 2257 18499156 - J Urol. 2008 Jul;180(1):410-1; author reply 411 |
References_xml | |
SSID | ssj0014572 |
Score | 2.4271855 |
Snippet | Surgical technique, patient characteristics and method of pathological review may influence surgical margin status. We evaluated the incidence and location of... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 2385 |
SubjectTerms | Adult Aged Aged, 80 and over Blood Loss, Surgical - physiopathology Cohort Studies Follow-Up Studies Humans Laparoscopy - methods Male Middle Aged Neoplasm Recurrence, Local - epidemiology Neoplasm Recurrence, Local - pathology Neoplasm Staging Pain Measurement Pain, Postoperative - physiopathology Probability Prostate-Specific Antigen - blood Prostatectomy - instrumentation Prostatectomy - methods Prostatic Neoplasms - mortality Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery Retrospective Studies Robotics Survival Analysis Treatment Outcome |
Title | A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17936849 |
Volume | 178 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYKK632goB98JYPe6uC0jiNk2OFQBUSXOhK3JDt2Ae0bapsuwd-EX-I_8OM7dRJgRXLJapiN209X2fGn-dByE-hBnyghIFNTg4bFHCZo1yWKkpLsM5ccZ1JTBS-us7Gv9LL2-Ftr_fUilpaLuSpeng1r-QjUoV7IFfMkv0Pya4eCjfgNcgXriBhuL5LxiMfQu7bCFonErlz2yfUHgugqWp8Qhef9Vf3_yxrp--moka-2ea0VLKytVvhP4IMaP83WFGsdFnNscizcMc5c8wREXjuUE1d4SbsvtWv9QIbgcm3ZrY94JCLZr3gZd3h9VdEz2UdzicC34q5ECEePDC8ZyvaW0wDmTvWde2PVW76GIbSoTh4K1xEe7WcoCosunqb5y2AdrQwc22AXpgHx1Tcn97Dj_PlKzGUNm9PBhHPpxYwqLuy3FVU_ffoWsnuZmiDbPAcle81Ukj-aCsd8sRnb7lAw_Uvg3Vs_QPW9jrW55lsky0vJjpyyNshPT3bJZ-vfDjGV_I4ogGAtDIUAEhXAKSAD9oAEEcbANIGgNQDEN5DPQBpA0DaBiD1sKIdWNkPQADSAMDXZ34jk4vzydk48q0_IgUu-SLiIjNsyFRstCo1S4oY3HhZDIwBF1mlQvC8LONEggOmyrQwmjE9YCbVYPeZNMl3sjmrZnqP0NRoHsskMxwc5yKORZmBSSsLZgwssEj3yQ-3xHdzV97lrln8gzdHDsmXANMj8smAPtHH4Jwu5IkV9jN6x5lB |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comparison+of+the+incidence+and+location+of+positive+surgical+margins+in+robotic+assisted+laparoscopic+radical+prostatectomy+and+open+retropubic+radical+prostatectomy&rft.jtitle=The+Journal+of+urology&rft.au=Smith%2C+Jr%2C+Joseph+A&rft.au=Chan%2C+Robert+C&rft.au=Chang%2C+Sam+S&rft.au=Herrell%2C+S+Duke&rft.date=2007-12-01&rft.eissn=1527-3792&rft.volume=178&rft.issue=6&rft.spage=2385&rft_id=info:doi/10.1016%2Fj.juro.2007.08.008&rft_id=info%3Apmid%2F17936849&rft_id=info%3Apmid%2F17936849&rft.externalDocID=17936849 |